Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LGC Invests in US Genomics Laboratory Expansion

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
DNA and RNA extraction services will complement existing genotyping service and allow improved research and development support to North American researchers.

LGC has announced the expansion of its nucleic acid extraction service capacity into North America. The extraction service will complement existing capacity in Berlin and London, and will be delivered from the group’s genomics laboratory in Beverly, MA – north of Boston.

LGC Genomics has substantial experience in the nucleic acid extraction field, offering not only outsourcing options for a global customer base but also reagents and instrumentation for laboratories who wish to run their extraction work in-house. With a range of proprietary Nucleic Acid Extraction technologies, including the sbeadex® and KleargeneTM ranges, along with instruments that enable automation, LGC Genomics is well positioned to support both large and small scale research projects.

The extraction team’s experience and expertise in obtaining nucleic acids from a wide variety of biological matrices including blood, mouse tails, plant seeds and leaves, microbial cultures and forensic samples is a key element of the service. With a strong customer base in the Agricultural biotechnology sector, laboratory staff also have significant experience working in areas of disease research and drug development, and particularly with cohort studies where the efficient extraction of DNA from very large sample numbers followed by genotyping of those samples is critical to the research effort.

Steve Asquith, Head of Global Laboratory Operations said: “We’re really excited to announce this expansion, as the ability to offer combined extraction and genotyping services is increasingly important to many of our customers. DNA extraction is a necessary step before any genotyping work can be undertaken and this added capacity will allow us to provide greater support than ever before to an expanding global customer base - including many multinational research teams. The range of extraction solutions we provide, combined with our applications expertise, sets us apart and our laboratory experts deliver fit-for-purpose solutions that yield DNA of the appropriate quality and quantity for downstream processing. We understand the chemistries we use because most of them were developed by our own R&D teams: we use what we sell and sell what we use, and this has always been key to our portfolio of products and services. And of course once developed, optimized protocols are readily made available to customers for use in their own labs should they desire to do the work themselves”.

The Beverly lab, established in 2011, has been providing genotyping services based on the company’s proprietary KASP genotyping technology, and will begin extraction operations early in 2013. The expanded service capability will enable a more comprehensive genomics project support service for customers in the North American market, enabling full project delivery through a single supplier and significant efficiency gains.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!